publication . Article . 2016

To treat or not to treat: puberty suppression in childhood-onset gender dysphoria.

Rosalia Costa; Polly Carmichael; Marco Colizzi;
Open Access
  • Published: 19 Jul 2016
  • Country: United Kingdom
<p>Puberty suppression using gonadotropin-releasing-hormone analogues (GnRHa) has become increasingly accepted as an intervention during the early stages of puberty (Tanner stage 2-3) in individuals with clear signs of childhood-onset gender dysphoria. However, lowering the age threshold for using medical intervention for children with gender dysphoria is still a matter of contention, and is more controversial than treating the condition in adolescents and adults, as children with gender dysphoria are more likely to express an unstable pattern of gender variance. Furthermore, concerns have been expressed regarding the risks of puberty suppression, which are poor...
Persistent Identifiers
free text keywords: Urology, Gender variance, Clinical psychology, Treatment outcome, MEDLINE, Gender dysphoria, medicine.disease, medicine, Endocrinology, medicine.medical_specialty, business.industry, business, Internal medicine, Informed consent, Sexual dysfunction, medicine.symptom, Sexual maturity, Safety criteria
Any information missing or wrong?Report an Issue